Table 1 Demographic features of the patients.

From: A simple score derived from bone marrow immunophenotyping is important for prognostic evaluation in myelodysplastic syndromes

  Controls n = 15 MDS n = 95
Age (years) 40 (31–52) 67 (33–79)
Male/female 9/6 62/33
IPSS-R   
  Very low risk   13
  Low risk   34
  Intermediate   24
  High risk   17
  Very high risk   7
 WHO types   
 Refractory anemia   6
 5q-syndrome   2
 RCMD*   61
RAEB I**   12
RAEB II**   14
  1. *Refractory cytopenia with multilineage dysplasia, **Refractory anemia with excess of blasts.